Goldman Sachs’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-68,301
| Closed | -$24K | – | 4396 |
|
|
2018
Q2 | $24K | Sell |
68,301
-3,261
| -5% | -$1.15K | ﹤0.01% | 4114 |
|
|
2018
Q1 | $107K | Sell |
71,562
-190,044
| -73% | -$284K | ﹤0.01% | 4003 |
|
|
2017
Q4 | $371K | Buy |
261,606
+160,621
| +159% | +$228K | ﹤0.01% | 3573 |
|
|
2017
Q3 | $231K | Buy |
100,985
+3,805
| +4% | +$8.7K | ﹤0.01% | 3833 |
|
|
2017
Q2 | $131K | Sell |
97,180
-24,314
| -20% | -$32.8K | ﹤0.01% | 4083 |
|
|
2017
Q1 | $260K | Buy |
121,494
+354
| +0.3% | +$758 | ﹤0.01% | 3838 |
|
|
2016
Q4 | $534K | Sell |
121,140
-92,643
| -43% | -$408K | ﹤0.01% | 3416 |
|
|
2016
Q3 | $1.04M | Buy |
213,783
+92,111
| +76% | +$447K | ﹤0.01% | 3038 |
|
|
2016
Q2 | $402K | Buy |
121,672
+90,831
| +295% | +$300K | ﹤0.01% | 3458 |
|
|
2016
Q1 | $109K | Buy |
+30,841
| New | +$109K | ﹤0.01% | 4010 |
|